nach oben

Erschienen in:

01.03.2024 | News item

MARC December 2023 meeting highlights

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

At the meeting of the New Zealand Medicines Adverse Reactions Committee (MARC) held in December 2023, the Committee reviewed the risk of anticoagulant-related nephropathy (ARN) associated with oral anticoagulants such as warfarin, dabigatran, rivaroxaban and apixaban, said the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) in Prescriber Update. …

MARCs remarks: December 2023 meeting Internet Document : 7 Mar 2024. Available from: URL: https://www.medsafe.govt.nz/profs/PUArticles/March2024/MARCs-remarks-December-2023-meeting.html

Titel: MARC December 2023 meeting highlights
Publikationsdatum: 01.03.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-54693-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

MARC December 2023 meeting highlights

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Concurrent use of opioids and skeletal muscle relaxants: assessing comparative risk of injury due to oversedation

Clevidipine

Mycophenolate-mofetil/Prednisolone/Ursodeoxycholic-acid

Multiple drugs

mRNA COVID-19 vaccines not linked to postmenopausal bleeding

Enoxaparin-sodium